|
US2014011756A1
|
|
Method for Treatment of Inflammation
|
|
US2015050365A1
|
|
Treatment of Elaeis fruit products with antioxidants
|
|
US2013108716A1
|
|
Jatropha curcas processing method and products
|
|
AP201306861A0
|
|
Jatropha curcas processing methods and products
|
|
US2009299046A1
|
|
Self-assembling oligonucleotides and methods
|
|
US2010068224A1
|
|
Method for Producing Viral Vaccine and Therapeutic Peptide Antigens
|
|
US2009169576A1
|
|
Influenza combinatorial antigen vaccine
|
|
US2006024308A1
|
|
High affinity anti-TNF-alpha antibodies and method
|
|
AU2004254352A1
|
|
Look-through mutagenesis
|
|
CA2482863A1
|
|
Universal libraries for immunoglobulins
|
|
CA2482769A1
|
|
"doping" in walk-through mutagenesis
|
|
US8216599B2
|
|
Method for treatment of inflammation
|
|
CA2079802A1
|
|
Walk-through mutagenesis
|
|
KR0173131B1
|
|
Walk-through mutagenesis
|
|
EP0263172A1
|
|
Protein analogues of tissue plasminogen activator.
|
